Hjem › Kronisk lymfatisk leukæmi › Maine
Kronisk lymfatisk leukæmi kliniske forsøg i Maine
6 studier for Kronisk lymfatisk leukæmi søger deltagere på steder i Maine.
Byer i Maine
Officiel studietekst (engelsk)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- MaineHealth Maine Medical Center - Portland, Portland
- MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
RekruttererFase 3
Alder 65 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07321652Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Waldo Hospital, Belfast
- Lafayette Family Cancer Center-EMMC, Brewer
- og 9 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 105, Westbrook
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07582432Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Cancer Care and IV Therapy - Brunswick, Brunswick
- Mid Coast Hospital, Brunswick
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT04269902Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
- New England Cancer Specialists, Scarborough
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 21. jan. 2026 · NCT06333262Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
- New England Cancer Specialists, Scarborough
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 5. dec. 2025 · NCT05168930Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.